Recent Posts
- Tavneos found safe, effective for AAV patients in real-world study July 24, 2024
- Using asthma medication off-label leads to disease remission in EGPA July 22, 2024
- New B-cell growth is impaired in AAV, study finds July 17, 2024
- Large-vessel involvement in AAV tied to neurological manifestations July 15, 2024
- Kidney failure risk factors ID’d in children with AAV kidney disease July 10, 2024
- Asthma drug may trigger rare ANCA-associated vasculitis July 8, 2024
- Nkarta gets green light from FDA to test NKX019 cell therapy in AAV July 3, 2024
- Tavneos better than prednisone for treating ear, nose, throat symptoms July 1, 2024
- Melodia buys rights to potential AAV therapy MDI-0151 June 26, 2024
- FDA clears Phase 2 trial of antibody therapy ruxoprubart in AAV June 24, 2024